Sennidin A

CAS No. 641-12-3

Sennidin A( —— )

Catalog No. M21676 CAS No. 641-12-3

Sennidin A has two hydroxyanthraquinone-like moieties exerts inhibition on NS3 helicase with IC50 values of 0.8 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1610 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sennidin A
  • Note
    Research use only, not for human use.
  • Brief Description
    Sennidin A has two hydroxyanthraquinone-like moieties exerts inhibition on NS3 helicase with IC50 values of 0.8 μM.
  • Description
    Sennidin A has two hydroxyanthraquinone-like moieties exerts inhibition on NS3 helicase with IC50 values of 0.8 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Akt
  • Recptor
    Akt|GLUT|PI3K
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    641-12-3
  • Formula Weight
    538.46
  • Molecular Formula
    C30H18O10
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(c(cc1O)cc([C@H]([C@H](c2cccc(O)c22)c3cc(C(O)=O)cc(O)c3C2=O)c2c3c(O)ccc2)c1C3=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Necrosis targeted combinational theragnostic approach using radioiodinated Sennidin A in rodent tumor models.Oncotarget. 2014 May 30;5(10):2934-46.
molnova catalog
related products
  • Dehydroglyasperin C

    Dehydroglyasperin C, a isoflavone, is a potent NAD(P)H:oxidoquinone reductase (NQO1) and phase 2 enzyme inducer. Dehydroglyasperin C has antioxidant, neuroprotective, cancer chemopreventive, and anti-inflammatory activities.

  • Norathyriol

    Norathyriol is a potent PTP1B inhibitor with good cell permeability and oral availability.

  • B-Raf inhibitor 1 di...

    B-Raf inhibitor 1 is a potent and selective B-Raf inhibitor.